Hiroshi Wada
- Surgery top 0.5%
- Molecular Biology top 2%
- Oncology top 1%
- Cancer Research top 0.5%
- Pulmonary and Respiratory Medicine top 1%
- Co-authors
- Hiroaki NaganoHidetoshi EguchiYuichiro� DokiShigeru MarubashiMasaki MoriShogo KobayashiKoji UmeshitaKenichi Sakakura
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (82 papers)Acute Myocardial Infarction Research (72 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (69 papers)
- Cited by
- HepatologyCancer ResearchOncology
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Hiroshi Wada
471 papers receiving 8.8k citations
Peers
Comparison fields: 5 of 160
- Surgery 3.2k
- Molecular Biology 2.6k
- Oncology 2.3k
- Cancer Research 2.1k
- Pulmonary and Respiratory Medicine 1.9k
Countries citing papers authored by Hiroshi Wada
This map shows the geographic impact of Hiroshi Wada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Wada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Wada more than expected).
Fields of papers citing papers by Hiroshi Wada
This network shows the impact of papers produced by Hiroshi Wada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Wada. The network helps show where Hiroshi Wada may publish in the future.
Co-authorship network of co-authors of Hiroshi Wada
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Wada. A scholar is included among the top collaborators of Hiroshi Wada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Wada. Hiroshi Wada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 5 | |
| 7 | 6 | |
| 8 | 3 | |
| 9 | 2 | |
| 10 | 8 | |
| 11 | 10 | |
| 12 | 8 | |
| 13 | 5 | |
| 14 | 12 | |
| 15 | 58 | |
| 16 | 8 | |
| 17 | 0 | |
| 18 | Comparison of the resource utilization between simultaneous strategy and staged strategy to treat two-vessel coronary artery disease by percutaneous coronary intervention. | 2 |
| 19 | 1 | |
| 20 | 103 |
About Hiroshi Wada
Hiroshi Wada is a scholar working on Hepatology, Cardiology and Cardiovascular Medicine and Surgery, having authored 497 papers that have together received 8.9k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (82 papers), Acute Myocardial Infarction Research (72 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (69 papers). The work is most often cited by research in Hepatology (1.7k citations), Cancer Research (2.1k citations) and Oncology (2.3k citations). Hiroshi Wada has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Hiroaki Nagano, Hidetoshi Eguchi, Yuichiro� Doki, Shigeru Marubashi, Masaki Mori, Shogo Kobayashi, Koji Umeshita, Kenichi Sakakura, Shin‐ichi Momomura and Yutaka Takeda. Their work appears in journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.